Benchmark Starts Ligand Pharma (LGND) at Buy
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $58.77 -0.41%
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 24
Rating Summary:
9 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 24
Join SI Premium – FREE
Benchmark analyst Robert Wasserman initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Buy rating.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $92.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein Starts Confluent Inc (CFLT) at Outperform, 'Data streaming gone viral'
- BofA Securities Starts Virtu Financial (VIRT) at Buy, 'Taking a contrarian view'
- Piper Sandler bullish on 'attractively valued' LendingClub (LC)
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
